ResMed (RMD) revenue was $5.7B in FY2026 (+10% YoY). The tables below show the complete quarterly and annual revenue history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Revenue
Fiscal Year
Revenue
YoY
2026
$5.7B
+10%
2025
$5.1B
+10%
2024
$4.7B
+11%
2023
$4.2B
+18%
2022
$3.6B
+12%
2021
$3.2B
+8%
2020
$3.0B
+13%
2019
$2.6B
+11%
2018
$2.3B
+13%
2017
$2.1B
+12%
2016
$1.8B
+10%
2015
$1.7B
+8%
2014
$1.6B
+3%
2013
$1.5B
+11%
2012
$1.4B
+10%
2011
$1.2B
+14%
2010
$1.1B
+19%
2009
$921M
Recent Quarterly Revenue
Quarter
Revenue
Q2 2026
$1.5B
Q1 2026
$1.4B
Q4 2025
$1.4B
Q3 2025
$1.3B
Q2 2025
$1.3B
Q1 2025
$1.3B
Q4 2024
$1.3B
Q3 2024
$1.2B
Q2 2024
$1.2B
Q1 2024
$1.2B
Q4 2023
$1.2B
Q3 2023
$1.1B
Source: RMD on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.